Read More Pharma Industry News UK approves Lilly’s Alzheimer’s drug but labels it ‘too expensive’ for NHS use The UK has approved Eli Lilly’s new Alzheimer’s treatment, donanemab, which has shown promise in slowing cognitive decline.… byPallavi MadhirajuOctober 23, 2024